Histrelin hydrogel implant: The company completed enrollment in an open-label U.S. Phase III trial of its Histrelin long-acting LHRH hydrogel implant in a total

Hydro Med Sciences Inc., Cranbury, N.J. Product: Histrelin hydrogel implant Business: Cancer Therapeutic category: Receptor agonist Target: Luteinizing hormone-releasing hormone (LHRH) Description: S...